
Amy E. Juedes
Examiner (ID: 7188)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1249 |
| Issued Applications | 438 |
| Pending Applications | 166 |
| Abandoned Applications | 692 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11090697
[patent_doc_number] => 20160287665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'DENDRITIC CELL MODULATORY MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 14/865197
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 25316
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14865197
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/865197 | DENDRITIC CELL MODULATORY MOLECULE | Sep 24, 2015 | Abandoned |
Array
(
[id] => 13968325
[patent_doc_number] => 10213496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Regulatory T cell epitopes, compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/857693
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 16
[patent_no_of_words] => 22044
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/857693 | Regulatory T cell epitopes, compositions and uses thereof | Sep 16, 2015 | Issued |
Array
(
[id] => 10491275
[patent_doc_number] => 20150376296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/851983
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 32219
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851983 | Compositions and methods for immunotherapy | Sep 10, 2015 | Issued |
Array
(
[id] => 10476382
[patent_doc_number] => 20150361396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/837702
[patent_app_country] => US
[patent_app_date] => 2015-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 67383
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14837702
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/837702 | T cell balance gene expression, compositions of matters and methods of use thereof | Aug 26, 2015 | Issued |
Array
(
[id] => 11971190
[patent_doc_number] => 20170275344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/506770
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 60000
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506770 | POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS | Aug 25, 2015 | Abandoned |
Array
(
[id] => 10978469
[patent_doc_number] => 20160175412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE'
[patent_app_type] => utility
[patent_app_number] => 14/834665
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7124
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834665
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834665 | PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE | Aug 24, 2015 | Abandoned |
Array
(
[id] => 10705522
[patent_doc_number] => 20160051669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR SELECTIVELY MODULATING TREGS'
[patent_app_type] => utility
[patent_app_number] => 14/832915
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 29768
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832915
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832915 | COMPOSITIONS AND METHODS FOR SELECTIVELY MODULATING TREGS | Aug 20, 2015 | Abandoned |
Array
(
[id] => 10459561
[patent_doc_number] => 20150344576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'HUMAN ANTI-KIR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/829170
[patent_app_country] => US
[patent_app_date] => 2015-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 48866
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/829170 | HUMAN ANTI-KIR ANTIBODIES | Aug 17, 2015 | Abandoned |
Array
(
[id] => 14422593
[patent_doc_number] => 10316086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Anti-human Igb antibody
[patent_app_type] => utility
[patent_app_number] => 15/501626
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 15118
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501626 | Anti-human Igb antibody | Aug 4, 2015 | Issued |
Array
(
[id] => 11851717
[patent_doc_number] => 20170226209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG'
[patent_app_type] => utility
[patent_app_number] => 15/500615
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13353
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500615 | AN ANTI-CD45RC ANTIBODY FOR USE AS DRUG | Jul 30, 2015 | Abandoned |
Array
(
[id] => 10678327
[patent_doc_number] => 20160024472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'Generation of Dendritic Cells from Monocytic Dendritic Precursor Cells with GM-CSF in the Absence of Additional Cytokines'
[patent_app_type] => utility
[patent_app_number] => 14/814315
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11382
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/814315 | Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines | Jul 29, 2015 | Issued |
Array
(
[id] => 17266381
[patent_doc_number] => 11191785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
[patent_app_type] => utility
[patent_app_number] => 14/810064
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 93
[patent_figures_cnt] => 109
[patent_no_of_words] => 21530
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14810064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/810064 | Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs | Jul 26, 2015 | Issued |
Array
(
[id] => 10678325
[patent_doc_number] => 20160024470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/806403
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8454
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14806403
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/806403 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS | Jul 21, 2015 | Abandoned |
Array
(
[id] => 11704580
[patent_doc_number] => 20170173078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System'
[patent_app_type] => utility
[patent_app_number] => 15/325265
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30761
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325265 | Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system | Jul 9, 2015 | Issued |
Array
(
[id] => 10491254
[patent_doc_number] => 20150376275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/753886
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 94978
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/753886 | ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS | Jun 28, 2015 | Abandoned |
Array
(
[id] => 11820620
[patent_doc_number] => 20170209557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'METHOD FOR PREPARING DENDRITIC CELLS WITH INCREASED SPECIFIC GENE EXPRESSION, AND COMPOSITION FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES, CONTAINING DENDRITIC CELLS PREPARED USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/320010
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9282
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320010 | Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same | Jun 22, 2015 | Issued |
Array
(
[id] => 11743972
[patent_doc_number] => 20170198044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR SAFE AND EFFECTIVE IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/320783
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 42308
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320783 | COMPOSITIONS AND METHODS FOR SAFE AND EFFECTIVE IMMUNOTHERAPY | Jun 22, 2015 | Abandoned |
Array
(
[id] => 12044569
[patent_doc_number] => 09822161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'ILT3 polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/733432
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 58
[patent_no_of_words] => 15416
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733432
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733432 | ILT3 polypeptides and uses thereof | Jun 7, 2015 | Issued |
Array
(
[id] => 11541748
[patent_doc_number] => 20170095573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ALLERGY AND INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/316040
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18163
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 55
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316040 | METHODS AND COMPOSITIONS FOR TREATING ALLERGY AND INFLAMMATORY DISEASES | Jun 1, 2015 | Abandoned |
Array
(
[id] => 10365866
[patent_doc_number] => 20150250871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/723268
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18606
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723268
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/723268 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS | May 26, 2015 | Abandoned |